# High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients

> **NCT03598452** · NA · COMPLETED · sponsor: **Aier School of Ophthalmology, Central South University** · enrollment: 33 (actual)

## Conditions studied

- Infection Viral
- Uveitis, Posterior

## Interventions

- **DRUG:** Ganciclovir

## Key facts

- **NCT ID:** NCT03598452
- **Lead sponsor:** Aier School of Ophthalmology, Central South University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-06
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2018-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03598452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03598452, "High-dose Intravitreal Injection of Ganciclovir for the Treatment of CMVR in HIV-negative Patients". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03598452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*